Medical Design & Outsourcing

Compremium’s Quantis CVP is a breakthrough for noninvasive cardiac pressure measurement

Compremium recently won FDA Breakthrough Device designation for its noninvasive Quantis CVP (central venous pressure) ...
Nasdaq

Study Finds Noninvasive, Continuous Masimo PVi® Monitoring More Valuable Than Central Venous Pressure Measurement for Guiding Fluid Management During Surgery

Dr. Eralp Çevikkalp and colleagues at Celal Bayar University in Turkey, noting the importance of intraoperative fluid management during surgery and the drawbacks of traditional invasive, static fluid ...
Business Wire

Teleflex Receives FDA 510(k) Clearance for CVP Monitoring Indication on the ArrowADVANTAGE 5™ Pressure-Injectable PICC

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, today announced its ArrowADVANTAGE 5 pressure-injectable ...
Finanznachrichten

Compremium AG: Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA's TAP Program

Novel solution aims to transform clinical pathways for critical hemodynamic monitoring Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...